Clinical Trial

A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 11, 2025 (before its estimated September 22, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will evaluate the effect and safety of 608 in patients with nr-axSpA.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-24.
Status change: Not Yet Recruiting → Recruiting 2025-03-06
Trial Details
NCT Number NCT06222671
Lead Sponsor Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions Axial Spondyloarthritis
Enrollment 180 participants
Start Date 2024-03-22
Primary Completion 2025-09-22 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-11